RxDoctor Payments Data

Nirali Patel, DO

Internal Medicine · Geneva, ILNPI 1720115041

Payments from drug & device makers

$1,312in general payments, 2019–2025

Across 67 payments — averaging $19.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$277
  • Lilly USA, LLC$200
  • Novo Nordisk$131
  • GSK$131
  • Amgen$110
  • Currax Pharmaceuticals LLC$102
  • plus $361 from 11 others

What the payments were for

  • Food & beverage$1,28798%
  • Education$252%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,312 in reported general payments places this provider in the 80th percentile of 5,182 internal medicine providers in Illinois.

See all internal medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$263,583
Medicare patients
447
Services billed
3,440

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide33$45,200
JanuviaSitagliptin Phosphate32$38,468
TrulicityDulaglutide28$30,047
XareltoRivaroxaban16$15,739
TradjentaLinagliptin12$11,273
RybelsusSemaglutide11$10,750
Lantus SolostarInsulin Glargine,hum.Rec.Anlog29$6,174
Levothyroxine Sodium471$4,475
SynthroidLevothyroxine Sodium47$3,138
Atorvastatin Calcium330$3,082
Rosuvastatin Calcium184$2,216
Amlodipine Besylate226$1,956
Omeprazole121$1,901
Fluticasone-SalmeterolFluticasone Propion/Salmeterol12$1,766
Lisinopril195$1,667

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$131$55,94944 claims
Lilly USA, LLCTrulicity$200$30,04728 claims
AbbVieSynthroid$277$3,13847 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 5,182 internal medicine providers in Illinois.

Other internal medicine in Geneva

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →